(Q39079661)

8 September 2017

Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer (English)

1 reference

8 September 2017

Daiki Mochizuki

6

0 references

Thomas E. Carey

object named as

Thomas E Carey

8

0 references

author name string

Yuki Misawa

1

1 reference

8 September 2017

Kiyoshi Misawa

2

1 reference

8 September 2017

Takeharu Kanazawa

3

1 reference

8 September 2017

Takayuki Uehara

4

1 reference

8 September 2017

Shori Endo

5

1 reference

8 September 2017

Takashi Yamatodani

7

1 reference

8 September 2017

Hiroyuki Mineta

9

1 reference

8 September 2017

language of work or name

English

0 references

publication date

10 October 2013

1 reference

8 September 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

Cancer

1 reference

8 September 2017

120

1 reference

8 September 2017

205-213

1 reference

8 September 2017

2

1 reference

Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes

8 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

Galanin and galanin receptor type 1 suppress proliferation in squamous carcinoma cells: activation of the extracellular signal regulated kinase pathway and induction of cyclin-dependent kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

Epigenetic inactivation of galanin receptor 1 in head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

Galanin has tumor suppressor activity and is frequently inactivated by aberrant promoter methylation in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

Galanin receptor subtype 2 suppresses cell proliferation and induces apoptosis in p53 mutant head and neck cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

Galanin receptor subtype GalR2 mediates apoptosis in SH-SY5Y neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

Galanin decreases proliferation of PC12 cells and induces apoptosis via its subtype 2 receptor (GalR2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

DCC promoter hypermethylation in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

Overexpression of cyclin D1 correlates with sensitivity to cisplatin in squamous cell carcinoma cell lines of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

Gene silencing in cancer in association with promoter hypermethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

Loss of chromosome arm 18q with tumor progression in head and neck squamous cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

The galanin receptor type 2 initiates multiple signaling pathways in small cell lung cancer cells by coupling to G(q), G(i) and G(12) proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

G protein-coupled receptors: novel targets for drug discovery in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

Using intravital microscopy to observe bevacizumab-mediated anti-angiogenesis in human head and neck squamous cell carcinoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

Methylation of death-associated protein kinase is associated with cetuximab and erlotinib resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

Association Between Hypermethylated Tumor and Paired Surgical Margins in Head and Neck Squamous Cell Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

inferred from DOI database lookup

7 January 2021

based on heuristic

Genome-wide identification of possible methylation markers chemosensitive to targeted regimens in colorectal cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28411

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.28411

1 reference

8 September 2017

1 reference